CN1233373C - 治疗脊椎疾病的中药组合物 - Google Patents
治疗脊椎疾病的中药组合物 Download PDFInfo
- Publication number
- CN1233373C CN1233373C CNB031340563A CN03134056A CN1233373C CN 1233373 C CN1233373 C CN 1233373C CN B031340563 A CNB031340563 A CN B031340563A CN 03134056 A CN03134056 A CN 03134056A CN 1233373 C CN1233373 C CN 1233373C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- grams
- olibanum
- myrrha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 201000010099 disease Diseases 0.000 claims description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 15
- 241000717739 Boswellia sacra Species 0.000 claims description 11
- 239000004863 Frankincense Substances 0.000 claims description 11
- 241001057584 Myrrha Species 0.000 claims description 11
- 241000271039 Agkistrodon Species 0.000 claims description 10
- 241000131808 Scolopendra Species 0.000 claims description 10
- 241000522620 Scorpio Species 0.000 claims description 10
- 239000009490 scorpio Substances 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 7
- 208000029761 vertebral disease Diseases 0.000 abstract 2
- 241000258920 Chilopoda Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000271897 Viperidae Species 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000035943 smell Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 210000003275 diaphysis Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗治疗脊椎疾病的中药组合物,该组合物由白花蛇、全蝎、蜈蚣、乳香、没药构成。该种中药组合物是一种外敷药,对各种脊椎疾病具有相当理想的疗效,同时,对人体不会产生任何副作用。
Description
技术领域
本发明涉及一种治疗脊椎疾病的中药组合物。
背景技术
脊椎包括:颈椎、胸椎、腰椎、骶椎和尾椎。上述椎骨骨体之间是靠一种形状为圆盘的软垫来连接,由此支撑着人体活动,而此软垫即为椎间盘,它的主要作用是承受压力,缓冲震荡并使脊椎活动自如。正是由于椎间盘的重要作用,所以,一旦椎间盘错位将影响肢体的活动,可以说,椎间盘疾病是脊椎疾病的主要表现形式。而这种疾病产生的主要原因是长期承受外部压力,身体着凉,肌肉痉挛、老化及骨刺等原因和其它疾病所致。
按照中医疗法治疗椎间盘疾病主要通过按摩和口服药等进行治疗。其治疗机理主要是疏通经络和活血来达到治疗目的。按摩主要调整神经功能,不能彻底治愈椎间盘疾病;而口服中药有各种不同配方,如CN1065132C公告的“治疗腰间盘突出的中药制剂”,该专利主要选用了红参、三七、红花、土虫、麝香、血蝎、没药、乳香8味中药原料配制而成。可见,治疗此种疾病有多种中药组合配方,治疗的目的也主要是通调经脉、活血祛瘀。上述中药配方多为十几味或近十几位中药构成,其中药组份的配比也相对比较复杂和难于制备。但,对彻底治疗椎间盘疾病的药物组物,特别是外敷药现还在探索之中。
技术方案
本发明的任务是提供一种通过简单配方来治愈脊椎疾病的中药组合物。
本发明所提出的治疗脊椎疾病的中药组合物由白花蛇、全蝎、蜈蚣、乳香、没药构成,且各组份的重量比为白花蛇∶全蝎∶蜈蚣∶乳香∶没药=1∶0.8-1.2∶0.4-0.6∶0.3-0.5∶0.5-0.7。据《本草纲目》中记载:白花蛇气味甘,咸,温,有毒,可治疗骨节疼痛,筋脉拘急等病症;蜈蚣气味辛,温,有毒,主治各种中毒;全蝎气味甘、辛,平,有毒,主治诸风瘾疹,中风半身不遂,手足抽掣等;乳香气味微温,无毒,主风水毒肿,去恶气除秽气,瘾疗痒毒;没药味苦,平,无毒,主治破血痛,疗金疮杖疮,诸恶疮痔漏等症。
该中药组合物各组份的重量配比为:白花蛇∶全蝎∶蜈蚣∶乳香∶没药=1∶0.8-1∶0.5-0.6∶0.3-0.5∶0.5-0.6。
本发明所提出的中药组合物经对豚鼠和SD大鼠动物实验与临床研究表明,该中药组合物具有明显的镇痛、抗炎及对软组织损伤的治疗作用。在皮肤过敏实验中,将30只豚鼠共分为三组,一组为采用本发明;二组采用膏药基质组;三组为阳性对照组(采用2.4-二硝基氯化苯以1%的致敏浓度溶入膏药基质),实验表明豚鼠无过敏现象发生(参见表1)。另外,用本发明所提出的中药组合物还对80只SD大鼠进行了长期的毒性实验,即将大鼠按重量平均分成4组(参见表2),每天给药分别为0.25g/Kg,0.5g/Kg,1.0g/Kg,每天换药一次,连续给药90天,经血液生化指标连续监测结果表明均在正常值范围内,经统计学处理各组间无明显差异。而经对大鼠病理学检查也显示出大鼠脏器均未见药物引起的明显毒性病理改变(参见表2)。同时利用本发明所提出的中药组合物经过对动物长期大剂量使用,对血象、血液生化、病理检测均未见明显改变,未见明显毒副作用。
本发明所提出的中药组合物对492例患有腰痛和/或坐骨神经痛,及颈椎痛病人进行临床治疗。在治疗中,每天外敷该组合物一份,一个月为一疗程,治疗2-3个疗程。在远期疗效观察中,停药一年后经统计表明,总有效率达93%以上,并且没有出现过敏和毒副作用。
表1本发明对豚鼠的皮肤过敏实验
组别 | 例数 | 致敏率(%) | 平均反应值 | |||
6小时 | 24小时 | 48小时 | 72小时 | |||
本发明组 | 10 | 0 | 0 | 0 | 0 | 0 |
膏药基值组 | 10 | 0 | 0 | 0 | 0 | 0 |
阳性对照组 | 10 | 100 | 1 | 0.96 | 0.72 | 0 |
表2本发明对大鼠长期毒性脏器引起的影响(X±S)
脏器 | 日期 | 对照组 | 小剂量组 | 中剂量组 | 大剂量组 |
心 | D60 | 0.49±0.03 | 0.45±0.05 | 0.46±0.05 | 0.47±0.06 |
D82 | 0.48±0.04 | 0.38±0.03 | 0.42±0.06 | 0.43±0.05 | |
肝 | D60 | 3.8±0.3 | 3.5±0.3 | 3.5±0.3 | 3.5±0.3 |
D82 | 3.5±0.4 | 3.9±0.3 | 3.3±0.5 | 3.6±0.4 | |
脾 | D60 | 0.289±0.04 | 0.282±0.07 | 0.284±0.05 | 0.270±0.04 |
D82 | 0.264±0.11 | 0.289±0.03 | 0.238±0.04 | 0.253±0.06 | |
肺 | D60 | 0.94±0.26 | 0.80±0.49 | 0.58±0.09 | 0.59±0.12 |
D82 | 0.65±0.31 | 0.58±0.08 | 0.58±0.09 | 0.58±0.07 | |
肾 | D60 | 0.99±0.99 | 0.85±0.05 | 0.43±0.06 | 0.45±0.06 |
D82 | 0.34±0.09 | 0.75±0.06 | 0.75±0.06 | 0.74±0.05 | |
肾上腺 | D60 | 0.033±0.01 | 0.029±0.01 | 0.025±0.01 | 0.028±0.01 |
D82 | 0.033±0.01 | 0.032±0.01 | 0.029±0.01 | 0.030±0.01 | |
脑 | D60 | 0.69±0.11 | 0.68±0.12 | 0.62±0.16 | 0.65±0.13 |
D82 | 0.66±0.09 | 0.65±0.14 | 0.56±0.12 | 0.63±0.11 | |
睾丸 | D60 | 1.42±0.15 | 1.38±0.14 | 1.45±0.15 | 1.40±0.12 |
D82 | 1.43±0.15 | 1.32±0.15 | 1.29±0.07 | 1.31±0.09 | |
子宫 | D60 | 0.46±0.13 | 0.42±0.05 | 0.38±0.08 | 0.39±0.09 |
D82 | 0.46±0.08 | 0.40±0.08 | 0.35±0.04 | 0.35±0.07 |
具体实施方式:
实施例1:取白花蛇100克、全蝎80克、蜈蚣60克、乳香50克、没药60克,将上述药物各自粉碎后再混合均匀,并制成膏状后将其分成350份,每次给药一份,外敷于患处。
实施例2:取白花蛇100克、全蝎100克、蜈蚣50克、乳香40克、没药70克,按上述方法制成膏状后分成350份,用法同上。
实施例3:取白花蛇100克、全蝎110克、蜈蚣60克、乳香30克、没药50克,按上述方法制成膏状后分成350份,用法同上。
Claims (2)
1、一种治疗脊椎疾病的中药组合物,其特征在于:该组合物由白花蛇、全蝎、蜈蚣、乳香、没药构成,其中,该组合物中各组份的重量比为:白花蛇∶全蝎∶蜈蚣∶乳香∶没药=1∶0.8-1.2∶0.4-0.6∶0.3-0.5∶0.5-0.7。
2、根据权利要求1所述的中药组合物,其特征在于:该中药组合物各组份的重量配比为:白花蛇∶全蝎∶蜈蚣∶乳香∶没药=1∶0.8-1∶0.5-0.6∶0.3-0.5∶0.5-0.6。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031340563A CN1233373C (zh) | 2003-09-25 | 2003-09-25 | 治疗脊椎疾病的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031340563A CN1233373C (zh) | 2003-09-25 | 2003-09-25 | 治疗脊椎疾病的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1528355A CN1528355A (zh) | 2004-09-15 |
CN1233373C true CN1233373C (zh) | 2005-12-28 |
Family
ID=34286118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031340563A Expired - Fee Related CN1233373C (zh) | 2003-09-25 | 2003-09-25 | 治疗脊椎疾病的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1233373C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101288758B (zh) * | 2008-06-06 | 2012-02-08 | 马新民 | 一种镇痛药物 |
CN102727601B (zh) * | 2011-04-12 | 2014-02-12 | 罗伟雄 | 一种治疗腰椎间盘突出症的外敷贴剂 |
-
2003
- 2003-09-25 CN CNB031340563A patent/CN1233373C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1528355A (zh) | 2004-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1272066C (zh) | 一种止痒药物组合物 | |
CN109432269A (zh) | 一种中药组合物以及制备方法、用途 | |
CN1233373C (zh) | 治疗脊椎疾病的中药组合物 | |
CN1824194A (zh) | 一种纯中药外用减肥药物 | |
CN115414456B (zh) | 一种治疗痔病的中药组合物及其应用 | |
CN104474108A (zh) | 一种治疗急性阑尾炎的中药制剂及制备方法 | |
CN100482295C (zh) | 蜂胶药豆颈椎枕 | |
CN101797371B (zh) | 一种用于减肥按摩的药物组合物 | |
CN107898989A (zh) | 一种治疗阻塞性睡眠呼吸暂停综合征的中药组合物及其制备方法 | |
CN102908582A (zh) | 一种治疗妇女血瘀型癥瘕的中药组合物及其制备方法 | |
CN108066572B (zh) | 一种治疗膝关节滑膜炎的膏药及其制备方法 | |
CN1131051C (zh) | 治疗颈椎病的药物及制备方法 | |
CN108904705A (zh) | 一种治疗绝经后女性慢性痛风性关节炎的中药组合物 | |
CN116763882B (zh) | 一种三九贴及其制备方法与应用 | |
CN1047947C (zh) | 骨结核外敷药膏及其制备工艺 | |
CN102512505B (zh) | 一种治疗骨刺的中成药 | |
CN108310163A (zh) | 一种追风祛湿活血中药制剂及其制备方法 | |
RU2076731C1 (ru) | Средство и способ повышения неспецифической резистентности организма при заболеваниях внутренних органов | |
CN1315200A (zh) | 一种治疗腰椎间盘突出症的外用药 | |
CN118416187A (zh) | 一种在“三伏季”使用的具有健脾祛湿散寒功效的中药组合物及其制备方法 | |
CN1329061C (zh) | 麝香药灸丸及其制备方法 | |
CN117045765A (zh) | 一种过敏性鼻炎贴及其制备方法 | |
CN111617182A (zh) | 一种舒筋活络元活膏及其制备方法 | |
CN118105443A (zh) | 一种治疗腰痛的中药组合物 | |
CN118356460A (zh) | 一种治疗功能性便秘的中药方剂及其制备方法、应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |